Quick Takeaways
- Braeden Lichti filed SCHEDULE 13G for enVVeno Medical Corporation Common Stock, $0.00001 par value per share.
- Disclosed ownership: 5%.
- Date of event: 10 Feb 2026.
Braeden Lichti - 10 Feb 2026 SCHEDULE 13G Report for enVVeno Medical Corporation Common Stock, $0.00001 par value per share
- Filing Manager
- Braeden Lichti
- Reporting Manager
- Braeden Lichti
- Shares outstanding
- 656,455 shares
- Disclosed Ownership
- 33,151 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Feb 2026, 16:28:33 UTC
- Date of event
- 10 Feb 2026
- Next filing
- 20 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Braeden Lichti disclosed 5% ownership in enVVeno Medical Corporation Common Stock, $0.00001 par value per share on 10 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Feb 2026, 16:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Braeden Lichti | 5% | 33,151 | 13,022 | 20,129 | /s/ Braeden Lichti | Braeden Lichti | |
| Northstrive Fund II LP | 3.1% | 20,129 | 0 | 20,129 | /s/ Braeden Lichti | Braeden Lichti/Manager |